Related Experiment Video
Updated: Apr 12, 2026

An Ex vivo Assay to Study Candida albicans Hyphal Morphogenesis in the Gastrointestinal Tract
Published on: July 1, 2020
[Secondary antifungal prophylaxis in hematological malignancy patients with previous invasive fungal disease]
Ming-Juan Liu1,2, Wen-Rong Huang1, Li Yu1
1Department of Hematology and BMT center, Chinese PLA General Hospital, Beijing 100853, China.
Abstract:
Invasive fungal disease (IFD) causes a high morbidity and mortality in patients with hematological malignancies. Reactivation of IFD after chemotherapy or hematopoietic stem cell transplantation (HSCT) is very common and associated with poor prognosis. Secondary antifungal prophylaxis (SAP) is effective in preventing IFD recurrence. With effective SAP, a history of IFD is not an absolute contraindication to allogeneic HSCT or continuation of high-dose chemotherapy. In recent years, a variety of antifungal drugs such as voriconazole, itraconazole, AmB and caspofungin have been found to be effective for SAP. However, its management during granulocytopenia and immunosuppression remains challenging. This review summarizes the current status of SAP in patients with hematological malignancies.
Insights
Secondary antifungal prophylaxis (SAP) effectively prevents invasive fungal disease (IFD) recurrence in patients with hematological malignancies. SAP allows for continued chemotherapy or stem cell transplantation despite IFD history.
Area of Science:
- Hematology
- Infectious Diseases
- Oncology
Background:
- Invasive fungal disease (IFD) significantly increases morbidity and mortality in hematological malignancy patients.
- Reactivation of IFD post-chemotherapy or stem cell transplantation (HSCT) is common and linked to poor outcomes.
Purpose of the Study:
- To review the current strategies and challenges of secondary antifungal prophylaxis (SAP) in patients with hematological malignancies.
Main Methods:
- Literature review of studies on secondary antifungal prophylaxis in hematological malignancy patients.
- Analysis of the efficacy and safety of various antifungal agents used for SAP.
Main Results:
- Secondary antifungal prophylaxis (SAP) is effective in preventing IFD recurrence.
- Effective SAP enables HSCT or high-dose chemotherapy continuation in patients with a history of IFD.
- Several antifungal drugs, including voriconazole, itraconazole, AmB, and caspofungin, are effective for SAP.
Conclusions:
- Secondary antifungal prophylaxis is crucial for managing invasive fungal disease in hematological malignancy patients.
- Management of SAP during granulocytopenia and immunosuppression remains a clinical challenge.
- This review provides an overview of the current landscape of SAP in this vulnerable patient population.
More Related Videos
Related Concept Videos
Antifungal Agents
Bone Marrow Sampling and Transplants
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy...
Fungal Phylum Microsporidia
Transmission-based Precautions II: Airborne and Protective Environment
Airborne precautions:
Use airborne precautions when treating patients known or suspected to have diseases that spread through the air—for example, tuberculosis or measles. These organisms are present in smaller droplets expelled by an infected person and...

